Adverse Events in Pediatric Critical Care Nonsurvivors With a Low Predicted Mortality Risk: A Multicenter Case Control Study*

被引:3
|
作者
Verlaat, Carin [1 ]
Zegers, Marieke [1 ]
Klein, Richard [2 ]
van Waardenburg, Dick [3 ]
Kuiper, Jan Willem [4 ]
Riedijk, Maaike [5 ]
Kneyber, Martin [6 ]
Timmers, Brigitte [7 ]
van Heerde, Marc A. [5 ]
Hazelzet, Jan [8 ]
van der Hoeven, Johannes [1 ]
Lemson, Joris [1 ]
机构
[1] Radboud Univ Nijmegen, Dept Intens Care, Med Ctr, Nijmegen, Netherlands
[2] Leiden Univ, Dept Intens Care, Med Ctr, Leiden, Netherlands
[3] Maastricht Univ, Dept Pediat Intens Care, Med Ctr, Maastricht, Netherlands
[4] Erasmus Univ, Sophia Childrens Hosp, Dept Pediat Intens Care, Med Ctr, Rotterdam, Netherlands
[5] Univ Amsterdam, Dept Pediat Intens Care, Med Ctr, Amsterdam, Netherlands
[6] Univ Med Ctr Groningen, Dept Pediat Intens Care, Groningen, Netherlands
[7] Univ Med Ctr Utrecht, Dept Pediat Intens Care, Utrecht, Netherlands
[8] Erasmus Univ, Dept Publ Hlth, Med Ctr, Rotterdam, Netherlands
关键词
adverse events; cohort studies; outcome; patient safety; pediatric critical care; PATIENT SAFETY; PREVENTABLE DEATHS; CHILDREN; UNIT; PREVALENCE; HOSPITALS; INDEX; PICU;
D O I
10.1097/PCC.0000000000003103
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
OBJECTIVES:Some patients with a low predicted mortality risk in the PICU die. The contribution of adverse events to mortality in this group is unknown. The aim of this study was to estimate the occurrence of adverse events in low-risk nonsurvivors (LN), compared with low-risk survivors (LS) and high-risk PICU survivors and nonsurvivors, and the contribution of adverse events to mortality. DESIGN:Case control study. Admissions were selected from the national Dutch PICU registry, containing 53,789 PICU admissions between 2006 and 2017, in seven PICUs. PICU admissions were stratified into four groups, based on mortality risk (low/high) and outcome (death/survival). Random samples were selected from the four groups. Cases were "LN." Control groups were as follows: "LS," "high-risk nonsurvivors" (HN), and "high-risk survivors" (HS). Adverse events were identified using the validated trigger tool method. SETTING:Patient chart review study. PATIENTS:Children admitted to the PICU with either a low predicted mortality risk (< 1%) or high predicted mortality risk (>= 30%). INTERVENTIONS:None. MEASUREMENTS AND MAIN RESULTS:In total, 419 patients were included (102 LN, 107 LS, 104 HN, and 106 HS). LN had more complex chronic conditions (93.1%) than LS (72.9%; p < 0.01), HN (49.0%; p < 0.001), and HS (48.1%; p < 0.001). The occurrence of adverse events in LN (76.5%) was higher than in LS (13.1%) and HN (47.1%) (p < 0.001). The most frequent adverse events in LN were hospital-acquired infections and drug/fluid-related adverse events. LN suffered from more severe adverse events compared with LS and HS (p < 0.001). In 30.4% of LN, an adverse event contributed to death. In 8.8%, this adverse event was considered preventable. CONCLUSIONS:Significant and preventable adverse events were found in low-risk PICU nonsurvivors. 76.5% of LN had one or more adverse events. In 30.4% of LN, an adverse event contributed to mortality.
引用
收藏
页码:4 / 16
页数:13
相关论文
共 50 条
  • [41] Adverse drug events caused by three high-risk drug-drug interactions in patients admitted to intensive care units: A multicentre retrospective observational study
    Klopotowska, Joanna E.
    Leopold, Jan-Hendrik
    Bakker, Tinka
    Yasrebi-de Kom, Izak
    Engelaer, Frouke M.
    de Jonge, Evert
    Haspels-Hogervorst, Esther K.
    van den Bergh, Walter M.
    Renes, Maurits H.
    Jong, Bas T.
    Kieft, Hans
    Wieringa, Andre
    Hendriks, Stefaan
    Lau, Cedric
    van Bree, Sjoerd H. W.
    Lammers, Hendrick J. W.
    Wierenga, Peter C.
    Bosman, Rob J.
    de Jong, Vincent M.
    Slijkhuis, Mirjam
    Franssen, Eric J. F.
    Vermeijden, Wytze J.
    Masselink, Joost
    Purmer, Ilse M.
    Bosma, Liesbeth E.
    Hoeksema, Martin
    Wesselink, Elsbeth
    de Lange, Dylan W.
    de Keizer, Nicolette F.
    Dongelmans, Dave A.
    Abu-Hanna, Ameen
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (01) : 164 - 175
  • [42] Independent risk factors for adverse events associated with propofol-based pediatric sedation performed by anesthesiologists in the radiology suite: a prospective observational study
    Lee, Jeong-Rim
    Lee, Jae Hoon
    Lee, Hye-Mi
    Kim, Nayeon
    Kim, Myoung Hwa
    EUROPEAN JOURNAL OF PEDIATRICS, 2021, 180 (05) : 1413 - 1422
  • [43] Clinical and organizational risk factors for mortality during deterioration events among pediatric oncology patients in Latin America: A multicenter prospective cohort
    Agulnik, Asya
    Cardenas, Adolfo
    Carrillo, Angela K.
    Bulsara, Purva
    Garza, Marcela
    Alfonso Carreras, Yvania
    Alvarado, Manuel
    Calderon, Patricia
    Diaz, Rosdali
    de Leon, Claudia
    del Real, Claudia
    Huitz, Tania
    Martinez, Angelica
    Miralda, Scheybi
    Montalvo, Erika
    Negrin, Octavia
    Osuna, Alejandra
    Perez Fermin, Clara Krystal
    Pineda, Estuardo
    Soberanis, Dora
    Juarez Tobias, Maria Susana
    Lu, Zhaohua
    Rodriguez-Galindo, Carlos
    CANCER, 2021, 127 (10) : 1668 - 1678
  • [44] Associations between nurse education and experience and the risk of mortality and adverse events in acute care hospitals: A systematic review of observational studies
    Audet, Li-Anne
    Bourgault, Patricia
    Rochefort, Christian M.
    INTERNATIONAL JOURNAL OF NURSING STUDIES, 2017, 80 : 128 - 146
  • [45] Mortality Following Clostridioides difficile Infection in Europe: A Retrospective Multicenter Case-Control Study
    Czepiel, Jacek
    Krutova, Marcela
    Mizrahi, Assaf
    Khanafer, Nagham
    Enoch, David A.
    Patyi, Marta
    Deptula, Aleksander
    Agodi, Antonella
    Nuvials, Xavier
    Pituch, Hanna
    Wojcik-Bugajska, Malgorzata
    Filipczak-Bryniarska, Iwona
    Brzozowski, Bartosz
    Krzanowski, Marcin
    Konturek, Katarzyna
    Fedewicz, Marcin
    Michalak, Mateusz
    Monpierre, Lorra
    Vanhems, Philippe
    Gouliouris, Theodore
    Jurczyszyn, Artur
    Goldman-Mazur, Sarah
    Wultanska, Dorota
    Kuijper, Ed J.
    Skupien, Jan
    Biesiada, Grazyna
    Garlicki, Aleksander
    ANTIBIOTICS-BASEL, 2021, 10 (03):
  • [46] Adverse events leading to intensive care unit admission in a low-and-middle-income-country: A prospective cohort study and a systematic review
    Pedro, Rodolpho Augusto de Moura
    Besen, Bruno Adler Maccagnan Pinheiro
    Mendes, Pedro Vitale
    Gomes, Augusto Cezar Marins
    de Carvalho, Marcelo Ticianelli
    Malbouisson, Luiz Marcelo Sa
    Park, Marcelo
    Taniguchi, Leandro Utino
    JOURNAL OF CRITICAL CARE, 2024, 80
  • [47] Evaluating potential unexpected adverse events and mortality after oral analgesics administration in fracture care-a cohort study
    Muhammad, Zehra Abdul
    Ahmad, Tashfeen
    Rashid, Haroon
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [48] Factors associated with risk of major adverse cardiovascular events in patients with rheumatoid arthritis: a nationwide, population-based, case-control study
    Chen, Yen-Ju
    Liu, Shih-Chia
    Lai, Kuo-Lung
    Tang, Kuo-Tung
    Lin, Ching-Heng
    Chen, Yi-Ming
    Tseng, Chih-Wei
    Chang, Yu-Mei
    Gotcher, Donald F.
    Chiou, Chuang-Chun
    Weng, Shao-Jen
    Chen, Hsin-Hua
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2021, 13
  • [49] Assessment of the risk of vascular adverse events by Doppler ultrasound in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: a case control study
    Ellithy, Hend N.
    Amin, Nermein S. A. E. -A.
    Mattar, Mervat M.
    Farawela, Hala M.
    Mohammed, Moataz F.
    El Hussiny, Noha M.
    Abdelwahab, Mohamed S.
    Moly, Rasha S. M. A.
    Yacoub, Maha F. Y.
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2025, 50 (01) : 100 - 106
  • [50] Derivation and Validation a Risk Model for Acute Kidney Injury and Subsequent Adverse Events After Cardiac Surgery: A Multicenter Cohort Study
    Zhang, Hang
    Yu, Min
    Wang, Rui
    Fan, Rui
    Zhang, Ke
    Chen, Wen
    Chen, Xin
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2022, 15 : 7751 - 7760